VCBeat Health Contact Us
Home Bayer's KERENDIA® (Finerenone) Hits Primary Endpoint in FIND-CKD Phase III Trial, Securing New Evidence for Non-Diabetic CKD Indication

Bayer's KERENDIA® (Finerenone) Hits Primary Endpoint in FIND-CKD Phase III Trial, Securing New Evidence for Non-Diabetic CKD Indication

Jun 05, 2026 19:23 CST Updated 19:51